Literature DB >> 16452927

Mechanisms of genetic robustness in RNA viruses.

Santiago F Elena1, Purificación Carrasco, José-Antonio Daròs, Rafael Sanjuán.   

Abstract

Two key features of RNA viruses are their compacted genomes and their high mutation rate. Accordingly, deleterious mutations are common and have an enormous impact on viral fitness. In their multicellular hosts, robustness can be achieved by genomic redundancy, including gene duplication, diploidy, alternative metabolic pathways and biochemical buffering mechanisms. However, here we review evidence suggesting that during RNA virus evolution, alternative robustness mechanisms may have been selected. After briefly describing how genetic robustness can be quantified, we discuss mechanisms of intrinsic robustness arising as consequences of RNA-genome architecture, replication peculiarities and quasi-species population dynamics. These intrinsic robustness mechanisms operate efficiently at the population level, despite the mutational sensitivity shown by individual genomes. Finally, we discuss the possibility that viruses might exploit cellular buffering mechanisms for their own benefit, producing a sort of extrinsic robustness.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16452927      PMCID: PMC1369264          DOI: 10.1038/sj.embor.7400636

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  59 in total

1.  High frequency of cryptic deleterious mutations in Caenorhabditis elegans.

Authors:  E K Davies; A D Peters; P D Keightley
Journal:  Science       Date:  1999-09-10       Impact factor: 47.728

2.  The rate of adaptation in asexuals.

Authors:  H A Orr
Journal:  Genetics       Date:  2000-06       Impact factor: 4.562

3.  Little evidence for synergism among deleterious mutations in a nonsegmented RNA virus.

Authors:  S F Elena
Journal:  J Mol Evol       Date:  1999-11       Impact factor: 2.395

4.  Effect of deleterious mutation-accumulation on the fitness of RNA bacteriophage MS2.

Authors:  M de la Peña; S F Elena; A Moya
Journal:  Evolution       Date:  2000-04       Impact factor: 3.694

5.  Lack of evolutionary stasis during alternating replication of an arbovirus in insect and mammalian cells.

Authors:  I S Novella; C L Hershey; C Escarmis; E Domingo; J J Holland
Journal:  J Mol Biol       Date:  1999-04-02       Impact factor: 5.469

6.  Heat shock cognate protein 70 is a cell fusion-enhancing factor but not an entry factor for human T-cell lymphotropic virus type I.

Authors:  D Fang; Y Haraguchi; A Jinno; Y Soda; N Shimizu; H Hoshino
Journal:  Biochem Biophys Res Commun       Date:  1999-08-02       Impact factor: 3.575

7.  Re-emergence of vesicular stomatitis in the western United States is associated with distinct viral genetic lineages.

Authors:  L L Rodriguez; T A Bunch; M Fraire; Z N Llewellyn
Journal:  Virology       Date:  2000-05-25       Impact factor: 3.616

8.  Unusual distribution of mutations associated with serial bottleneck passages of human immunodeficiency virus type 1.

Authors:  E Yuste; C López-Galíndez; E Domingo
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

9.  Drastic fitness loss in human immunodeficiency virus type 1 upon serial bottleneck events.

Authors:  E Yuste; S Sánchez-Palomino; C Casado; E Domingo; C López-Galíndez
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

10.  Evolvability of an RNA virus is determined by its mutational neighbourhood.

Authors:  C L Burch; L Chao
Journal:  Nature       Date:  2000-08-10       Impact factor: 49.962

View more
  67 in total

1.  Dynamics of a plant RNA virus intracellular accumulation: stamping machine vs. geometric replication.

Authors:  Fernando Martínez; Josep Sardanyés; Santiago F Elena; José-Antonio Daròs
Journal:  Genetics       Date:  2011-04-21       Impact factor: 4.562

Review 2.  Mutational fitness effects in RNA and single-stranded DNA viruses: common patterns revealed by site-directed mutagenesis studies.

Authors:  Rafael Sanjuán
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-06-27       Impact factor: 6.237

3.  Evolutionary constraints on chaperone-mediated folding provide an antiviral approach refractory to development of drug resistance.

Authors:  Ron Geller; Marco Vignuzzi; Raul Andino; Judith Frydman
Journal:  Genes Dev       Date:  2007-01-15       Impact factor: 11.361

4.  Epistasis correlates to genomic complexity.

Authors:  Rafael Sanjuán; Santiago F Elena
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-18       Impact factor: 11.205

5.  Quasi-species evolution in subdivided populations favours maximally deleterious mutations.

Authors:  Brendan D O'Fallon; Frederick R Adler; Stephen R Proulx
Journal:  Proc Biol Sci       Date:  2007-12-22       Impact factor: 5.349

6.  Complementation and epistasis in viral coinfection dynamics.

Authors:  Hong Gao; Marcus W Feldman
Journal:  Genetics       Date:  2009-03-06       Impact factor: 4.562

7.  In silico genetic robustness analysis of secondary structural elements in the miRNA gene.

Authors:  Wenjie Shu; Ming Ni; Xiaochen Bo; Zhiqiang Zheng; Shengqi Wang
Journal:  J Mol Evol       Date:  2008-10-22       Impact factor: 2.395

8.  A nonadaptive origin of a beneficial trait: in silico selection for free energy of folding leads to the neutral emergence of mutational robustness in single domain proteins.

Authors:  Rafael F Pagan; Steven E Massey
Journal:  J Mol Evol       Date:  2013-12-21       Impact factor: 2.395

9.  An enhanced single base extension technique for the analysis of complex viral populations.

Authors:  Dale R Webster; Armin G Hekele; Adam S Lauring; Kael F Fischer; Hao Li; Raul Andino; Joseph L DeRisi
Journal:  PLoS One       Date:  2009-10-16       Impact factor: 3.240

10.  The evolution of two homologues of the core protein VP6 of epizootic haemorrhagic disease virus (EHDV), which correspond to the geographical origin of the virus.

Authors:  S J Anthony; K E Darpel; S Maan; G Sutton; H Attoui; P P C Mertens
Journal:  Virus Genes       Date:  2009-10-15       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.